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Abstract: Post-mortem imaging is increasingly used in forensic practice in cases of natural
deaths related to cardiovascular diseases, which represent the most common causes
of death in developed countries. While radiological examination is generally considered
to be a good complement for conventional autopsy, it was thought to have limited
application in cardiovascular pathology. At present, MDCT, CT-angiography and
cardiac MRI are used in post-mortem radiological investigation of cardiovascular
pathologies.This review presents the actual state of post-mortem imaging for
cardiovascular pathologies in cases of sudden cardiac death (SCD), taking into
consideration both the advantages and limitations.
The radiological evaluation of ischemic heart disease, the most frequent cause of SCD
in the general population of industrialised countries, includes the examination of the
coronary arteries and myocardium. Post-mortem CT angiography is very useful for the
detection of stenoses and occlusions of coronary arteries, but less so for the
identification of ischemic myocardium. MRI is the method of choice for the radiological
investigation of the myocardium in clinical practice, but its accessibility and application
are still limited in post-mortem practice.
There are very few reports implicating post-mortem radiology in the investigation of
other causes of SCD, such as cardiomyopathies, coronary artery abnormalities and
valvular pathologies. Cardiomyopathies representing the most frequent cause of SCD
in young athletes cannot be diagnosed by echocardiography, the most widely available
technique in clinical practice for the functional evaluation of the heart and the detection
of cardiomyopathies. Post-mortem CT-angiography and MRI have the potential to
detect advanced stages of diseases when morphological substrate is present, but
these methods have yet to be sufficiently validated for post-mortem cases. Genetically
determined channelopathies cannot be detected radiologically. This review underlines
the need to establish the role of post-mortem radiology in the diagnosis of SCD.
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Abstract 
Post-mortem imaging is increasingly used in forensic practice in cases of natural 
deaths related to cardiovascular diseases, which represent the most common causes 
of death in developed countries. While radiological examination is generally 
considered to be a good complement for conventional autopsy, it was thought to 
have limited application in cardiovascular pathology. At present, MDCT, CT-
angiography and cardiac MRI are used in post-mortem radiological investigation of 
cardiovascular pathologies. This review presents the actual state of post-mortem 
imaging for cardiovascular pathologies in cases of sudden cardiac death (SCD), 
taking into consideration both the advantages and limitations.  
The radiological evaluation of ischemic heart disease, the most frequent cause of 
SCD in the general population of industrialised countries, includes the examination of 
the coronary arteries and myocardium. Post-mortem CT angiography is very useful 
for the detection of stenoses and occlusions of coronary arteries, but less so for the 
identification of ischemic myocardium. MRI is the method of choice for the 
radiological investigation of the myocardium in clinical practice, but its accessibility 
and application are still limited in post-mortem practice.  
There are very few reports implicating post-mortem radiology in the investigation of 
other causes of SCD, such as cardiomyopathies, coronary artery abnormalities and 
valvular pathologies. Cardiomyopathies representing the most frequent cause of SCD 
in young athletes cannot be diagnosed by echocardiography, the most widely 
available technique in clinical practice for the functional evaluation of the heart and 
the detection of cardiomyopathies. Post-mortem CT-angiography and MRI have the 
potential to detect advanced stages of diseases when morphological substrate is 
present, but these methods have yet to be sufficiently validated for post-mortem 
cases. Genetically determined channelopathies cannot be detected radiologically. 
This review underlines the need to establish the role of post-mortem radiology in the 
diagnosis of SCD.  
Keywords: sudden cardiac death, post-mortem CT-angiography (PMCTA), cardiac 
post-mortem MRI (cardiac PMMR) 
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Introduction - Radiological post-mortem examination for cardiovascular 
pathologies 
Radiological imaging plays a very important role in the diagnosis of cardiac 
pathologies in the living. In forensic post-mortem practice, radiological examination 
has proven to be a very useful tool for cases such as gunshot wounds, physical child 
abuse and victim identification. In the last fifteen years computed tomography and 
magnetic resonance imaging (CT and MRI) have been increasingly used in routine 
forensic practice and research. Undetermined causes of death and sudden cardiac 
deaths represent an important part of forensic practice and these cases are 
increasingly investigated with modern radiological techniques. Radiological post-
mortem examination was initially considered to be of limited benefit and low accuracy 
for the investigation of cardiovascular pathologies [1]. The introduction of post-
mortem CT-angiography (PMCTA), which enables the investigation of the vascular 
lumen, has proven to be very promising [2-7] and the first post-mortem MRI (PMMR) 
studies have yielded interesting results for the investigation of ischemic myocardium 
[8,9]. 
The goal of this paper is to discuss the advantages and limitations of post-mortem 
imaging for the diagnosis of cardiac pathologies in sudden cardiac death. 
Sudden cardiac death 
Although definitions of sudden death and sudden cardiac death (SCD) vary greatly, 
the most widely accepted definition of SCD is a sudden and unexpected death that 
occurs within one hour of symptom-onset. For unwitnessed deaths, victims observed 
alive within 24 hours before death meet the definition [10,11]. The underlying cause 
of sudden death is most frequently cardiovascular in origin, with ischemic heart 
disease being most common in the general population [11].  
Any sudden, unexpected or unexplained death warrants medico-legal investigation. 
Sudden cardiac death autopsies should be performed according to guidelines set by 
the fields of forensic medicine and cardiovascular pathology. Classical investigation 
of SCD includes the evaluation of clinical history, autopsy and histology examination, 
and sometimes the analysis of cardiac biomarkers and/or genetic analyses for 
channelopathies. No gold standards currently exist for the post-mortem radiological 
evaluation of cardiovascular pathologies.  
Epidemiology and causes of sudden cardiac death 
Cardiovascular pathologies are the most common causes of death in developed 
countries. In recent prospective studies using multiple sources in the United States, 
Netherlands, Ireland, and China, SCD rates range from 50 to 100 per 100,000 in the 
general population [12,13]. The true incidence of SCD remains unknown and is likely 
under-reported since sudden arrhythmic events are often misclassified as drownings, 
traffic traumas or epileptic seizures [14,15]. The most common clinical finding 
associated with SCD in the general population is ischemic heart disease. According 
to epidemiological studies, approximately 80% of SCD cases can be attributed to this 
disease. 10-15% of SCDs result from cardiomyopathies with a morphological 
substrate, such as hypertrophic cardiomyopathy (HCM), arrhythmogenic right 
ventricular cardiomyopathy/dysplasia (ARVC/D) and myocardial infiltrative diseases 
(i.e. sarcoidosis). In the remaining 5-10%, the cause of SCD is related to either a 
structurally abnormal congenital cardiac condition (i.e. coronary artery abnormalities) 
or to cardiac channelopathies [11]. 
The causes and incidences of SCD in younger individuals vary according to the study 
and population. The major limitation of SCD evaluation is the lack of adequate or 
available autopsies. In the Irish study comprising 116 victims between 14-35 years of 
age, the most frequent causes of death were sudden unexplained death syndrome 
(26.7%), coronary artery disease (20.7%), HCM (14.7%) and idiopathic left 
ventricular hypertrophy not fulfilling criteria for HCM (10.3%) [16]. In a recent 
retrospective study, Eckart et al. reviewed 902 non-traumatic sudden deaths in 
individuals with a mean age of 38 ± 11 years. They showed that in those <35 years of 
age the leading cause of death was sudden unexplained death (41.3%); whereas in 
those ≥35 years of age the leading cause of death was atherosclerotic coronary 
artery disease (73.2%) [17]. 
Sports-related SCD or SCD in athletes fall into a separate group. Mass media has 
focused a lot of attention on young athletes who die suddenly while training or during 
competition. Such deaths illustrate that vigorous exertion can transiently increase the 
risk of SCD and highlights the paradox that physical activity can have both a positive 
and a negative impact on an individual’s health. The reported causes of SCD among 
athletes differ between studies, with a high proportion due to HCM in the United 
States [18] and due to ARVC in Italy [19]. A Danish study performed in 2010 reported 
the incidence rate of SCD in competitive athletes to be higher than that of the general 
population. The most common autopsy findings were ARVC, sudden unexplained 
death and coronary artery disease [20]. 
Ischemic heart disease 
Ischemic heart disease (IHD) related to atherosclerotic disease and impaired cardiac 
blood supply continues to be the most frequent cause of death in the general 
population in industrialized countries [11]. IHD refers to a group of clinico-pathological 
conditions, which include angina pectoris (stable or unstable), acute myocardial 
infarction, chronic ischemic heart disease with or without heart failure and SCD. 
Plaque rupture is the primary underlying cause of luminal thrombosis, responsible for 
provoking acute coronary syndromes such as myocardial infarction and sudden 
cardiac death. The secondary mechanism, more frequent in younger individuals, is 
related to plaque erosion [21]. Instant death due to ventricular fibrillation or atrio-
ventricular block is a frequent complication of coronary thrombosis and is responsible 
for 50% of acute myocardial infarction mortality [22]. Chronic ischemic heart disease 
can be deemed the cause of death if at least one of the main coronary arteries has a 
narrowing of 75% or more, and complimentary analyses (i.e. toxicology and clinical 
chemistry) are negative. Also non-atherosclerotic coronary artery diseases can 
provoke ischemic events. These diseases include late stage of obliterative intimal 
thickening, coronary artery dissection, ostial stenosis, coronary arteritis and 
aneurysm, coronary emboli, coronary artery spasm and myocardial bridging. 
In clinical practice, the diagnosis of IHD is largely based on the presence or absence 
of specific symptoms. The diagnostic gold standards are electrocardiography and 
cardiac biomarkers. Stress testing and/or angiography are often used to identify and 
treat coronary artery disease. Invasive coronary angiography is currently the “gold 
standard” for assessing coronary artery stenosis [5]. It can be used as a rule-out test 
in patients with low to intermediate likelihood of disease, as shown by Schlattmann et 
al. in a recent meta-regression analysis [23]. Cardiac multi-detector computed 
tomography (MDCT), including contrast-enhanced MDCT coronary angiography, is 
considered to be a powerful diagnostic tool for the assessment of coronary disease in 
acute and chronic cases [3]. CT angiography is the method of choice for the 
assessment of both the arterial lumen and wall disease. CT angiography has also 
proven to be useful for the assessment of the degree of myocardial perfusion and the 
detection of any previous infarctions with the measurement of myocardial attenuation 
using Hounsfield units. Decreased perfusion is associated with reduced myocardial 
enhancement. In addition, old infarctions show lower CT attenuation than recent 
ones [24]. Cardiac MRI is a reference standard for the assessment of ventricular 
function and may help identify and classify scars for risk stratification [25].  
The biggest clinical challenge is the detection of patients with vulnerable plaques that 
are subject to either plaque rupture or erosion. Even the combination of imaging 
techniques fails to accurately pinpoint vulnerable plaques. It is recognised that 
coronary CT-angiography can detect two important features of coronary plaque 
vulnerability: a large, soft plaque and focal vascular remodelling [26]. Other 
morphological characteristics of a vulnerable plaque, such as thin cap fibroatheroma 
and a lipid core, can be identified with angioscopy, high frequency intravascular 
ultrasound, intravascular MRI and optical coherence tomography. Active 
inflammation in high-risk plaques can be detected using intravascular thermography 
[27]. Coronary artery calcifications, detectable by CT but not MRI imaging, are 
considered to be predictors of a cardiovascular event and plaque burden. There are, 
however, controversial opinions concerning the role of calcium, especially since 
some studies have suggested that it may be protective against the development of 
acute coronary syndrome [28]. 
The post-mortem investigation of IHD is different than in classical clinical practice as 
it is impossible to use certain techniques, such as electrocardiography and many of 
the laboratory analyses, after death. The post-mortem diagnosis of IHD is based on 
the evaluation of the coronary arteries and myocardium. The post-mortem 
angiographical examination of coronary arteries was initially performed in 1899, three 
years after the discovery of X-rays [29]. At present, coronary arteries are investigated 
using PMCT/PMCTA [6,4,2,3] and/or PMMR/PMMRA [30,31].  
A recent study performed on 23 forensic cases showed that PMCT is of limited 
diagnostic value for IHD. PMCTA, if correctly interpreted, is a reasonable tool to view 
the morphology of coronary arteries, rule out significant coronary artery stenosis, 
identify occlusions and direct sampling for histological examination. Radiological 
examination by PMCT or PMCTA enables the detection and documentation of 
coronary artery calcification better than classical autopsy. However, the visualisation 
and differentiation of PMCT artefacts has yet to be studied [3].  
PMMR examination of ischemic myocardium was first performed on 8 autopsy cases 
in 2006 by Jackowski et al. They demonstrated that PMMR enables the detection of 
myocardial infarction in situ and the estimation of infarct age based on signal 
behaviour [9]. A few authors have recently reported on the PMMR- based diagnosis 
of coronary artery disease related deaths [30,31,8]. Although the presence of a clot is 
highly indicative for a coronary event, PMMR cannot certainly differentiate between 
post-mortem clots and vital thromboses.  
PMCTA and PMMR have both their advantages and disadvantages for the post-
mortem examination of IHD. Although MRI is the method of choice for the radiological 
investigation of the myocardium (Fig. S1), the biggest advantage of PMCTA is its 
ability to investigate the vessel’s lumen, enabling the detection of stenoses and 
occlusions (Fig. 1). Both methods are associated with a risk of thrombi dislodgement, 
and they do not enable the differentiation between vital and artefactual post-mortem 
thrombus. Radiological techniques using injected agents are very useful for the 
detection of coronary stenoses and occlusions, but the diagnosis must be confirmed 
visually and/or histologically in order to rule out post-mortem artefact. The biggest 
disadvantages of both post-mortem techniques are that they require dedicated and 
expensive technical equipment as well as physicians experienced in the fields of 
post-mortem radiology and cardiovascular pathology.  
Cardiomyopathies 
In 2006, the expert consensus defined cardiomyopathies as an important and 
heterogeneous group of myocardial diseases associated with mechanical and/or 
electrical dysfunction, usually exhibiting inappropriate ventricular hypertrophy or 
dilatation due to a variety of causes that frequently are genetic. Cardiomyopathies are 
either confined to the heart or are part of generalized systemic disorders, often 
leading to cardiovascular death or progressive heart failure-related disabilities [32]. 
The most frequently involved cardiomyopathies in SCD, especially in young 
individuals, are HCM and ARVC. 
In the clinical setting echocardiography is the most commonly used tool for the 
detection of cardiomyopathies and the functional evaluation of the heart. MRI is 
becoming increasingly important, as it can acquire high-resolution images of the 
heart in any desired plane [33]. MRI can better differentiate tissue properties, is non-
invasive and has a higher resolution. Clinical MRI also has the potential to detect 
regional and diastolic ventricular dysfunction, which can represent early 
manifestations of ARVC. The current imaging tools cannot determine the aetiology of 
the cardiomyopathy, which is essential for both treatment and prognosis [34]. 
Hypertrophic cardiomyopathy/ athlete’s heart 
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac disease, 
with a prevalence of 1:500 in the general population. HCM is an autosomal dominant 
disease caused by mutations in genes encoding sarcomere proteins. It is also one of 
the most common causes of SCD in young individuals and young athletes.  In the 
clinical setting, HCM is defined by unexplained left ventricular hypertrophy without 
dilation of the ventricular chambers, in the absence of any other cardiac or systemic 
disease that could explain the hypertrophy. Clinically, HCM is usually characterized 
by a left ventricle wall thickness ≥ 15 mm, with 13 to 14 mm considered as borderline 
[35].   
HCM has a diverse phenotypic expression, ranging from a silent disease to very 
severe one. Imaging plays a key role in the diagnosis of HCM; transthoracic 
echocardiography remains the gold standard for the screening and initial evaluation 
of HCM [35]. Cardiac MRI is indicated in patients with suspected HCM when 
echocardiography is inconclusive or when additional information may have an impact 
on further management. Additional imaging techniques, including coronary 
angiography (invasive or CT- imaging) and positron emission tomography, may be 
indicated depending on the clinical picture. 
HCM must be differentiated from hypertensive heart disease and physiological 
remodelling in athletes, as athletic hearts and secondary causes of hypertrophy 
(i.e.hypertension and aortic stenosis) may mimic HCM. It is well recognized that that 
the border between physiological and pathological changes is poorly defined [10]. 
Cardiac MRI is very useful to show different enhancement patterns via late 
gadolinium enhancement in some forms of cardiac hypertrophy (cardiac amyloidosis, 
sarcoidosis, Fabry) [36]. The histological examination is necessary to detect 
constellation of hypertrophy, fibrosis and small vessel disease and myocyte disarray. 
These findings represent the gold standard for the pathological confirmation of the 
HCM diagnosis [37]. The combination of non-invasive cardiac imaging and genetic 
screening will further aid in the preclinical diagnosis and management of patients with 
HCM [36]. 
No post-mortem radiological observations have been reported for HCM, but PMMR 
alone or in conjunction with PMCTA should be considered, as previously suggested 
by Jackowski et al [38]. PMCT and PMCTA allow the observation of global cardiac 
hypertrophy (Fig. S2), which might have however many possible aetiologies. At 
present, the autopsy and histological examination remain the gold standard for the 
post-mortem diagnosis of HCM.  
Arrhythmogenic right ventricular cardiomyopathy 
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a genetically 
determined heart muscle disorder characterized by structural and functional 
abnormalities, mostly of the right ventricle resulting from progressive, fibro fatty 
replacement of the right ventricular myocardium starting from the epicardium. The left 
ventricle is occasionally involved as well. Fibro fatty replacement leads to wall 
thinning and aneurysm formation, typically located at the inferior, apical, and 
infundibular walls. Its estimated prevalence is between 1:1000 and 1:5000 in the 
general population [39,40]. The presence of fatty tissue in the right ventricular free 
wall is of limited diagnostic specificity as it is a common finding in normal hearts, 
particularly in obese and elderly individuals.  
The clinical diagnosis of ARVC is currently based on the presence of different 
standardized Task Force Criteria as right ventricular functional and structural 
changes, electrocardiographical depolarisation and repolarisation abnormalities, 
ventricular arrhythmias, fibro fatty replacement of the myocardium and a positive 
family history. The diagnosis can be established when different diagnostic criteria are 
present. An accurate post-mortem diagnosis of arrhythmogenic right ventricular 
cardiomyopathy (ARVC) is important for any surviving family members, as it is a 
hereditary disease and there are available treatment options for the prevention of 
sudden death [39,40].  
In patients with structurally severe disease, all cardiac imaging methods are likely to 
yield abnormal findings. Echocardiography is most often the first imaging method 
used for the assessment of index cases and family members since it is widely 
available and non-invasive. CT-angiography is very helpful for the detection of 
akinetic or dyskinetic bulging in the triangle of dysplasia. MRI is a powerful imaging 
method due to its greater ability for tissue characterization. While in morphologically 
severe forms MRI does not add to diagnosis, MRI with gadolinium enhancement has 
the potential to detect regional and diastolic ventricular dysfunction, most likely 
related to intramyocardial fibrosis, which can be an early manifestation of ARVC. 
Therefore MRI is able to detect early stages and subtle cases.  
The detection of fatty infiltration is not sufficient for the diagnosis of the disease, as it 
may present in healthy adults and patients with other myocardial diseases [41]. 
Considering that coronary artery disease is a common cause of left ventricular 
dilation and dysfunction which can mimic ARVC, this pathology should be excluded. 
MDCT coronary angiography has shown a negative predictive value of 100% in 
excluding significant CAD in patients with ARVC [24]. 
No comparative studies have been performed to evaluate the radiological aspects of 
ARVC in the post-mortem setting. Jackowski et al reported a case with fatty 
infiltration of the free right ventricular wall and thinning of the apical right ventricular 
wall visualised by PMMR, which was suggestive of ARVC [38]. It is possible to detect 
some radiological features of ARVC with PMCTA, such as fatty infiltration and right 
ventricular dilation (Fig. 2). However, considering the guidelines for the clinical 
diagnosis, and given the importance of the diagnosis for the next of kin, both the 
autopsy and histological examination remain the gold standards for the post-mortem 
diagnosis. 
Channelopathies 
Progress made in the fields of molecular biology and human genetics have resulted 
in the identification of the genetic origin of many cardiac diseases, which can lead to 
both structural (e.g. hypertrophic cardiomyopathy) and arrhythmogenic abnormalities 
(e.g. long QT syndrome, Brugada syndrome) which can result in SCD. Autopsy 
negative SCD are most often thought to be the result of sudden arrhythmic death 
syndrome. Sudden arrhythmic death syndrome cannot be detected with any of the 
aforementioned imaging techniques.  
Cardiac sarcoidosis / myocarditis 
Sarcoidosis is a multisystem granulomatous disease of an unknown aetiology, 
characterized by noncaseating granulomas in involved organs. The incidence of 
sarcoidosis varies with race. The prevalence is 10-40/100,000 persons in the United 
States and Europe, with an increased prevalence in African-Americans [42]. 
In clinical practice, the imaging methods used to evaluate sarcoidosis are 
echocardiography, nuclear medicine and more recently gadolinium-enhanced cardiac 
MRI [34]. In the post-mortem setting, PMMR and PMCT may prove to be useful for 
the establishment of the diagnosis and to direct sampling for histological examination, 
but no reports have been published to date (Fig. 3).  
Myocarditis is an acute or chronic inflammatory disease of the myocardium, 
characterized by myocardial inflammatory infiltrates with myocyte degeneration and 
necrosis. In current clinical practice, myocardial biopsy is essential for the diagnosis 
[43,44]. Echocardiography and cardiac MRI are likely to become the non-invasive 
standard radiological examinations for the investigation of myocarditis and to assist in 
the performance of guided biopsies from the areas of marked contrast enhancement 
[45,46].  
There are currently no reports on the post-mortem radiological imaging of 
myocarditis. The precise mapping of inflammatory myocardial lesions with cardiac 
MRI might increase the diagnostic yield of guided myocardial sampling, but the 
accessibility of MRI remains limited in the post-mortem setting. 
Valvular abnormalities 
Although rare in the general population, aortic stenosis and mitral valve prolapse are 
the most frequently reported valvulopathies to cause SCD in young individuals.  
In clinical practice, aortic valvular disease can be satisfactorily studied with Doppler 
echocardiography; whereas coronary angiography can be technically difficult and 
may increase potential risks [24]. PMCT and PMCTA enable the visualization of 
calcification in aortic stenosis (Fig. S3) but mitral valve prolapse cannot be detected 
with post-mortem radiological imaging as it is mainly a functional disorder. It is even 
difficult or impossible to prove its role in causing death with an autopsy examination.   
Coronary artery anomalies 
Coronary anomalies occur in <1% of the general population and can range from a 
benign incidental finding to the cause of SCD [47,48]. Classic coronary anomalies 
include those in which a coronary artery originates from the contra-lateral aortic sinus 
or the pulmonary artery with an anomalous course [49,50]. 
Although invasive angiography has historically been used to diagnose coronary 
anomalies, MDCT imaging techniques are now an accurate non-invasive alternative 
[51,50]. Coronary CT-angiography provides detailed visualisation of complex 
coronary artery anatomy and is currently the method of choice for the detection and 
classification of coronary artery anomalies [48]. MDCTA is considered to be superior 
to conventional angiography in delineating the ostial origin and proximal course of 
anomalous coronary arteries. In patients with myocardial bridging who present with 
chest pain or even myocardial infarction, MDCTA has the advantage of assessing the 
coronary artery lumen as well as the surrounding myocardium [24]. 
In the post-mortem setting, PMCTA allows for excellent visualization of coronary 
artery anatomy (Fig. 4). Okura et al presented a case report of SCD with a calcified 
coronary artery aneurysm related to Kawasaki disease which was visualized by 
PMCTA imaging [52]. 
Sudden postoperative deaths 
Sudden deaths can also occur in patients undergoing cardiovascular surgery. MDCT 
angiography allows for the non-invasive evaluation of coronary bypass graft patency 
with a high diagnostic accuracy [53,54]. MDCTA is a reliable non-invasive diagnostic 
method that can clearly display the stent lumen and is especially helpful for patient 
follow-up. This technique can be used to evaluate the full range of stent-related 
problems, such as stent thrombosis, jailed branches, edge stenosis, bifurcation 
stents, inadequate stent expansion and stent aneurysms [55]. 
In the post-mortem examination, PMCT allows for the detection of coronary stents 
and artificial heart valves, which can be difficult to visualize in the presence of severe 
calcifications. PMCTA can demonstrate the permeability of coronary bypass and can 
help guide autopsy dissection technique (Fig. 5). In occluded bypass grafts, classical 
dissection is necessary to rule out post-mortem artefact.    
Discussion 
The clinical diagnostic approach for cardiovascular pathologies is different than that 
involved in post-mortem forensic investigations. The clinician takes into account the 
anamnesis, clinical examination, electrocardiogram readings, radiological 
examination and measurement of cardiac biomarkers, to name a few. Many clinical 
diagnostic tools are useful for assessing function, and are of limited value in the post-
mortem setting. On the other hand, the autopsy renders a detailed visual assessment 
and histological examinations of the myocardium easily accessible. The importance 
of establishing a diagnosis is also different. In living patients the clinical diagnosis is 
essential for both treatment and prognosis; in forensic practice determining the cause 
of death can direct the juridical investigations. An autopsy diagnosis for genetically 
determined cardiac pathologies is also essential for the prevention of sudden death 
in living family members.  
The radiological cardiac examination differs in the pre and post-mortem setting. In the 
living, the radiological cardiac examination is aimed at the evaluation of structure and 
function. Cardiac physiology, filling pressures and valvular function can be assessed 
in detail by Doppler echocardiography [24]. The functional assessment is impossible 
after death, and the imaging techniques are limited to structural evaluations. Most 
post-mortem imaging findings are confirmed at autopsy, in order to rule out post-
mortem artefacts [56]. Advanced decomposition can destroy organ structure and gas 
related artifacts should be carefully analyzed [57]. That being said, post-mortem 
radiology has many advantages. The major advantage of postmortem radiological 
examination is that the artifacts related to heartbeats, for example, are not present. 
Radiation exposure is not a concern, and allows for the acquisition of high quality 
images. There are no motion related artifacts. Some specific examinations, such as 
CT coronary angiography, may be contraindicated in living due to the risk of an 
allergic response and/or the impairment of renal function, which are not an issue in 
the post-mortem setting. 
The contribution of post-mortem radiological imaging techniques is increasing in 
cardiovascular pathology, but there is currently no consensus on the role of the post-
mortem radiological examination in the autopsy diagnosis, especially for 
cardiovascular pathologies resulting in SCD. Cardiovascular pathologies present 
particular diagnostic challenges, both in the clinical and post-mortem setting. The 
guidelines for the clinical radiological examination have been established by many 
experts [35,40,58]. Often times, the radiological examination alone is unable to 
diagnose many of the hereditary cardiac diseases, such as ARVC, HCM and 
channelopathies. The validity of radiological post-mortem findings, without 
confirmation by classical autopsy, is not yet known. Most publications are based on 
very few observations and the results have yet to be independently verified. In this 
paper, we presented the state of the art for the radiological examination of 
cardiovascular pathologies. In post-mortem imaging, cardiovascular pathologies have 
been analysed by only a few groups [4,8,29,3,6,7]. While PMCTA allows for the 
morphological evaluation of coronary arteries and the detection of suspected 
stenoses and occlusions, PMMR provides superior soft tissue visualization 
[4,8,29,3,6,59]. Post-mortem imaging techniques, especially those associated with 
the intravascular injection of contrast, are able to demonstrate and document a 
number of cardiovascular pathologies, but some hereditary cardiac diseases, such as 
ARVC, HCM and channelopathies, cannot be diagnosed with these techniques. 
The need to establish the diagnostic value of post-mortem radiology as well as its 
degree of certitude has been suggested by many authors. In 2012 Roberts et al 
published a study undertaken at two UK centres between 2006 and 2008. They 
investigated 182 adult deaths that underwent whole-body CT, MRI and a full autopsy. 
They concluded that when compared with traditional autopsy, PMCT was a more 
accurate imaging technique than PMMR for establishing a cause of death. The most 
common misdiagnosis when using post-mortem imaging was ischemic heart disease, 
which represents the most common cause of death in the general population. The 
authors underline the potential risk of systematic errors in mortality statistics that 
would result if imaging were to replace conventional autopsy [59]. The radiological 
degree of certitude is important, especially in the forensic interpretation of the case. 
The interpretation of the autopsy findings and the medico-legal conclusions are of 
great interest for the police, investigating magistrate or prosecutor, lawyers and 
courts.  The interpretation should consider all reanimation and post-mortem artefacts 
[60,56]. In clinical radiology, many artefacts have been reported [61-63]. Radiological 
findings may also be incidental and unrelated to the cause of death. One report 
stated that a variety of findings suggestive of myocardial infarction were found on 
routine chest CT in patients who may not have had a prior diagnosis of ischemic 
heart disease [64]. The possible artefacts of post-mortem radiological examination 
should be carefully studied and considered when interpreting medico-legal cases 
which might involve civil or penal responsibilities. Misinterpretations of the 
morphological findings and complimentary exams can contribute to a miscarriage of 
justice. In a study published in 2012, Murken et al showed that the radiologic 
diagnoses were often discrepant from autopsy findings, and that autopsies can help 
radiologists sharpen their skills and can perhaps serve as quality control mechanisms 
for radiology, and vice-versa [65,66]. 
Evaluating of the cost/benefit of autopsies was suggested by some authors in order 
to consider post-mortem imaging as a complement and/or alternative to traditional 
clinical autopsies. If the goal of the autopsy is to determine the cause of death, the 
degree of certitude of the radiological diagnosis is very important. If an exact cause of 
death is not required, and if the goal of the autopsy is to exclude traumatic deaths, 
some autopsies may not be necessary. In selected cases, an external examination 
would be sufficient, while keeping in mind the limitations of this examination in the 
interpretation of the case.  
In our opinion, post-mortem radiology should be performed in cases where additional 
information concerning the cause of death should be obtained or if radiological 
imaging may help to document pathologies before performing the destructive 
autopsy, which would allow for a future independent review. In the field of the 
cardiovascular pathology, the post-mortem radiological examination is most often not 
sufficient to establish the exact cause of death and autopsy remains the gold 
standard. More studies are needed in order to establish the validity and limitations of 
the post-mortem radiological assessment of cardiovascular pathologies, mainly 
because of the numerous post-mortem artefacts. At present, there are no non-
invasive techniques that can replace the histological examination. The post-mortem 
radiological examination, followed by a complete autopsy, can help further the 
understanding and interpretation of the radiological examination in the living. The 
limitations of interpretation for the radiological post-mortem examination should be 
highlighted, especially in cases involving legal or ethical responsibilities. Over 
interpretation may contribute to a miscarriage of justice or to an incorrect clinical 
approach involving families of SCD victims. 
Legends: 
Fig. 1 Coronary artery thrombosis observed in PMCTA of a 47-year-old-man who 
died suddenly: while the native PMCT shows only a small calcification of the 
left intraventricular coronary artery (arrow in a), the arterial phase of the 
PMCTA (b) reveals a significant stenosis (arrow in b). A 3D-volume rendering 
reconstruction (c) clearly demonstrates the stenosis and its exact localisation. 
Histological examination in H&E stained section (d) of the concerned part of 
the artery shows advanced fibro lipid eccentric plaque and thrombotic material 
in the lumen. 
Fig. 2 18-year old athletic man who died suddenly while doing sport: PMCTA (a and 
b) showed the dilatation of the right ventricle, a fatty aspect of the ventricular
wall (arrows in a) and increased trabecularisation of the right ventricle. 
Conventional autopsy confirmed these findings, especially the presence of 
fatty infiltration in the right ventricular wall (arrows in c). Histological 
examination (d and e) allowed the classical diagnosis of ARVC concerning the 
right ventricle and the posterior wall of the left ventricle (Masson trichrome 
stain) 
Fig. 3 Multiorganic sarcoidosis involving the heart of a 35 year-old man who died 
suddenly while cycling. In PMCT (a), nodular formations in the lungs (arrow in 
a) were observed which arosed the suspicion of sarcoidosis as well as a
massive pulmonary oedema centered on the hilum indicating cardiac failure. 
Histological examination of the myocardium showed typical multiple lymphatic 
foci, sarcoid giant cells embedded in a fibrous background without surrounding 
necrosis, involving both ventricles and the ventricular septum (H&E staining) 
Fig. 4 Morphologies of coronary arteries visualised by PMCTA 
a) coronary arteries in a 33 year-old man who collapsed in a night club, just
after complaining about thoracic pain, electrocardiogram showed ventricular  
fibrillation. Reconstruction of PMCTA images allows the visualisation of a 
variant of coronary arteries with the circumflex artery originating from the right 
sinus  
b) another variant of coronary arteries: trifurcation of the left coronary artery  in
a 58- year-old man found dead at his home. The cause of death was attributed 
to an acute bronchopneumonia   
Fig. 5 Coronary artery stent (arrows) in native PMCT (a) and PMCTA (b). While the 
native CT-scan can only confirm the presence and localisation of the stent in 
the left interventricular artery, PMCTA proves the intact perfusion of the stent.  
c) Coronary bypass between the left internal mammary artery and the left
interventricular artery (yellow arrow) visualized by PMCTA, with an occlusion 
of the left interventricular artery in its middle part (black arrow). The red arrow 
indicates the right internal mammary artery.   
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